-
Continue reading →: The Tribunals Reforms Bill, 2021, passed by the Rajya Sabha
Bill to abolish 9 appellate tribunals, including the Intellectual Property Appellate Board (IPAB), The Tribunals Reforms Bill, 2021, has been passed by the Rajya Sabha on 9th August 2021. The bill was approved by Lok Sabha on August 3. All patent appeals, revocations etc which were filed before the IPAB,…
-
Continue reading →: E-Register of Designs
The E-Register of Designs has been made available on the website of Controller General of Patents Designs and Trademarks and can be accessed through the below URL: The E-Register of Designs
-
Continue reading →: Benefit of Section 107A extended to SMS Pharmaceuticals
The Delhi High Court, allowed an application of the Defendant, SMS Pharmaceuticals, under Order XXXIX Rule 4 of the Code of Civil Procedure, 1908 (CPC), seeking modification of the ex-parte ad interim order, dated 21st October, 2020 passed by the Court. Merck Sharp and Dohme Corporation (“the plaintiff”) has,…
-
Continue reading →: DB refuses interim relief to AstraZeneca
The division bench (DB) of the Delhi High Court has refused 9 appeals of AstraZeneca which were filed against the orders/judgments denying interim relief, in Patent infringement suits instituted by the appellants/plaintiffs, AstraZeneca AB, Sweden and AstraZeneca Pharma India Ltd. The challenge in the nine appeals was to two orders/judgments;…
-
Continue reading →: Review of the Intellectual Property Rights Regime in India by the standing committee on commerce
Department related parliamentary standing committee on commerce published its 161st report on Review of the Intellectual Property Rights Regime in India. The Department in the Report, observed and analysed the overall scenario of IPR regime in India and its contribution in promoting innovation and entrepreneurship in the country. The Report…
-
Continue reading →: Compulsory Licence Applications for Baricitinib
Natco and Bajaj Healthcare Pvt. Ltd. (BH) have filed for compulsory Licence (CL) applications for covid drug Baricitinib ( IN 270765). In the CL application both cite life threatening public health emergency which is currently prevailing in India due to the resurgence of the Covid-19 virus as the reason for…
-
Continue reading →: DHC grants injunction to FMC Corporation against Natco Pharma Ltd. and Best Crop Science LLP
The Delhi High Court (DHC) has recently granted an injunction to FMC Corporation (“the plaintiff”), against the defendant Natco Pharma Ltd and Best Crop Science LLP (“the Defendants”). The court has held that pending disposal of the suit, the defendant is restrained from manufacturing, using, selling, distributing, advertising, exporting, offering…
-
Continue reading →: Intellectual Property Division to deal with IPR cases
The Delhi High Court in a press release has informed about the creation of an Intellectual Property Division (IPD) to deal with all matters related to intellectual property rights (IPR). IPD creation is in view of the fact that the Tribunals Reforms (Rationalisation and Conditions of Service) Ordinance, 2021 led to…
-
Continue reading →: Intellectual Property Appellate Board Disbanded
The Government of India published The Tribunals Reforms (Rationalization and Conditions of Service) Ordinance, 2021 on 4th April 2021. With the publication of this Ordinance, the Intellectual Property Appellate Board has been disbanded. Appeals in all appealable orders issued by the Patent Office and revocation petitions shall now lie before…
-
Continue reading →: Government Proposes to Abolish IPAB
The Government of India introduced The Tribunals Reforms (Rationalisation andConditions of Service) Bill, 2021 in the Lok Sabha in February 2021. The Bill has been introduced with a view to streamline tribunals and proposes to abolish certain tribunals andauthorities and to provide a mechanism for filing appeals directly to the…
